PERINDOPRIL-AS perindopril arginine 5mg film-coated tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

perindopril arginine, Quantity: 5 mg

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

perindopril arginine

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: colloidal anhydrous silica; sodium starch glycollate type A; glycerol dibehenate; magnesium stearate; lactose monohydrate; maltodextrin; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350

Mode d'administration:

Oral

Unités en paquet:

10, 30

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

The treatment of hypertension; The treatment of heart failure. In such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (The safety and efficacy of perindopril arginine has not been demonstrated for New York Heart Association Category IV patients); and Patients with established coronary artery disease (see Clinical Trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Descriptif du produit:

Visual Identification: White, oval, biconvex, film-coated tablets engraved with two dots on one side and scored on both sides; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 6 Months; Container Temperature: Store below 30 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2015-08-07